ARCHIVES

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

November 11, 1994

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

Varmus Wins ASCO’s Science Of Oncology Award; Sawyers To Give Karnofsky Lecture.

January 28, 2005

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review

November 3, 1978

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009